Research Briefing
Rare Cancers Bill: HL Bill 124 of 2024–26
The Rare Cancers Bill is intended to incentivise research and investment into rare cancers, which tend to be more difficult to diagnose and treat than common cancers. The bill would require the secretary of state to promote research into rare cancers and to review licencing for medicines which treat rare conditions. It would also create a national speciality lead to promote and advise on research, as well as improved data sharing for contacting potential trial participants.